MIRZA, 1990 - Google Patents
jllafiter of $ l| ilofl (oplipMIRZA, 1990
- Document ID
- 2399736861273022105
- Author
- MIRZA M
- Publication year
External Links
- 108091005771 Peptidases 0 description 59
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sjöquist et al. | Protein A isolated from Staphylococcus aureus after digestion with lysostaphin | |
| Persson et al. | Calcium binding to the isolated β-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X | |
| Holleman et al. | The thrombin-like enzyme from Bothrops atrox snake venom. Properties of the enzyme purified by affinity chromatography on p-aminobenzamidine-substituted agarose. | |
| Bach et al. | Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine | |
| Ishiura et al. | Studies of a calcium-activated neutral protease from chicken skeletal muscle: I. Purification and characterization | |
| ES2236396T3 (en) | FACTOR IX CONJUGATES AND A BIOCOMPATIBLE POLYMER. | |
| US4245051A (en) | Human serum plasminogen activator | |
| JP2001511162A (en) | Polypeptide-polymer conjugates with attached and / or removed attachment groups | |
| Liepnieks et al. | The preparation and properties of bovine enterokinase. | |
| RU2093519C1 (en) | Method of enzymatic preparing fibroblast basic growth factor b fgf (10-155) and pharmaceutical composition based on thereof | |
| Groskopf et al. | Studies on the Active Center of Human Plasmin: THE SERINE AND HISTIDINE RESIDUES | |
| JPS62255435A (en) | Stable protein and stabilization of protein | |
| JPH06172201A (en) | Biologically active protein composition | |
| CA2189774A1 (en) | Recombinant hk2 polypeptide | |
| Hubbard et al. | Vitamin K-dependent carboxylase: affinity purification from bovine liver by using a synthetic propeptide containing the gamma-carboxylation recognition site. | |
| US4082612A (en) | Plasminogen activator complex | |
| Caliceti et al. | Active site protection of proteolytic enzymes by poly (ethylene glycol) surface modification | |
| JPH0631317B2 (en) | Trigramin, a polypeptide that inhibits platelet aggregation | |
| ES2434032T3 (en) | Dimeric and multimeric FVIIA compounds | |
| Melchior et al. | α2-Macroglobulin-mediated clearance of proteases from the plasma of the American horseshoe crab, Limulus polyphemus | |
| Punnappuzha et al. | Synthesis and characterization of polysialic acid–Uricase conjugates for the treatment of Hyperuricemia | |
| Ole-MoiYoi et al. | Structural studies of human urinary kallikrein (urokallikrein). | |
| MIRZA | jllafiter of $ l| ilofl (oplip | |
| ANDO et al. | High-performance liquid chromatographic assay of transglutaminase and its application to the purification of human erythrocyte transglutaminase and platelet factor XIII | |
| US4144131A (en) | Immobilization of enzymes on human tissue or erythrocytes |